The estimated Net Worth of John D Mc Dermott is at least $3.26 Million dollars as of 10 May 2018. John Dermott owns over 177,065 units of Endologix stock worth over $224,447 and over the last 17 years John sold ELGX stock worth over $3,030,962.
John has made over 11 trades of the Endologix stock since 2011, according to the Form 4 filled with the SEC. Most recently John exercised 177,065 units of ELGX stock worth $472,764 on 10 May 2018.
The largest trade John's ever made was exercising 250,000 units of Endologix stock on 27 March 2018 worth over $667,500. On average, John trades about 19,801 units every 65 days since 2008. As of 10 May 2018 John still owns at least 1,020,212 units of Endologix stock.
You can see the complete history of John Dermott stock trades at the bottom of the page.
John's mailing address filed with the SEC is 2, Musick, Irvine Spectrum, Irvine, Orange, California, 92618, United States of America.
Over the last 22 years, insiders at Endologix have traded over $72,068,611 worth of Endologix stock and bought 306,824 units worth $2,023,811 . The most active insiders traders include International, L.P. Elliott, Associates, L.P. Elliott, and Capital Management Lp Camber. On average, Endologix executives and independent directors trade stock every 27 days with the average trade being worth of $13,088. The most recent stock trade was executed by Dan Lemaitre on 4 September 2020, trading 51,844 units of ELGX stock currently worth $2,592.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, Nellix and Ovation. The company was founded in March 1992 and is headquartered in Irvine, CA.
Endologix executives and other stock owners filed with the SEC include: